Novo Nordisk A S (NVO) stock
NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)
Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –
Novo Nordisk A S net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Novo Nordisk A S
Novo Nordisk A S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?